ASCO® GI 2025 Insights: NRG-GI007 Trial - Final Safety Assessment & cCR Rate of CRT With Endoscopically Injected Oncolytic Virus OBP-301 in Medically Inoperable Esophageal Cancer | VuMedi

Find latest Gastric Cancer videos · 100+ videos

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

This video is featured in the Insights from 2025 ASCO® GI Annual Meeting

Insights from 2025 ASCO® GI Annual Meeting

ASCO® GI 2025 Insights: NRG-GI007 Trial - Final Safety Assessment & cCR Rate of CRT With Endoscopically Injected Oncolytic Virus OBP-301 in Medically Inoperable Esophageal Cancer

By Insights from 2025 ASCO® GI Annual Meeting FEATURING Geoffrey Ku

By Insights from 2025 ASCO® GI Annual Meeting FEATURING Geoffrey Ku

88 views

February 14, 2025

Comments 0

Login to view comments. Click here to Login